MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

CUSIP: 558868105

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
22,766,960
Total 13F shares
1,529,190
Share change
+196,023
Total reported value
$23,547,216
Price per share
$15.40
Number of holders
25
Value change
+$3,024,176
Number of buys
15
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q1 2017

As of 31 Mar 2017, MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,529,190 shares. The largest 10 holders included Capital World Investors, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC. This page lists 25 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.